PharmAust has secured a patent for its promising anti-cancer drug in another major market, this week adding Japan to a list that already includes Australia, China and the US. The new protection is the latest in a series of recent patent awards that are clearly impressing the market, with PharmAust stock up almost 50% in the past month.
07/06/2017 - 06:17
PharmAust anti cancer drug achieves patent in Japan
By Matt Birney
07/06/2017 - 06:17
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX